Skip to main content
TipRanks
Go Ultimate75% OFF

Intrasense SA (I8S) AI Stock Analysis

0 Followers
DE:I8S

Intrasense SA

(Frankfurt:I8S)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Recurring subscription modelA subscription-based licensing model creates recurring revenue and service relationships with healthcare institutions. Over months this improves revenue predictability, supports multi-year customer retention, and can enable more stable cash flow to fund product development and support investments.
Negative Factors
Negative margins and operating lossesNegative gross and net margins and persistent operating losses indicate the core business is not yet profitable. Over months this erodes reserves, limits reinvestment capacity, and makes breakeven harder to reach without sustained margin improvement or cost structure changes.

Intrasense SA (I8S) vs. iShares MSCI Germany ETF (EWG)

-40%-20%0%20%40%60%DE:I8S-29.80%EWG+9.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 10.61M
Dividend Yield
―
Average Volume (3M)
1,600
Price to Earnings (P/E)
-0.8
Beta (1Y)
0.17
Revenue Growth
-24.18%
EPS Growth
-120.44%
Country
Germany
Employees
76
Sector
Healthcare
Sector Strength
51
Industry
Medical - Healthcare Information Services

Intrasense SA Business Overview & Revenue Model

Company Description

Established in 2004 and headquartered in Montpellier, France, Intrasense S.A. specializes in the global development of sophisticated software for visualizing and analyzing diverse medical imaging data, marketed under its Myrian brand. The company's o...

Intrasense SA Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:I8S against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
FR:ALCGMFR:ALCGM60NeutralEUR 132.75M-8.85-5.44%―-0.98%―
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
FR:ALIKOFR:ALIKO46NeutralEUR 22.89M-5.31-22.49%―37.28%7.83%
FR:ALTHEFR:ALTHE46NeutralEUR 46.78M-5.74453.10%―-16.98%20.31%
FR:ALMDTFR:ALMDT43NeutralEUR 208.54M-3.54271.64%―2.16%-5.26%

* Healthcare Sector Average

Performance Comparison

0%50%100%DE:I8SFR:ALCGMFR:ALTHEFR:ALDMSFR:ALIKOFR:ALMDTDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:I8S and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:I8SIntrasense SA0.18-0.08-29.80%
FR:ALCGMCegedim SA9.47-2.68-22.06%
FR:ALTHETheraclion SA0.59-0.09-12.65%
FR:ALDMSDiagnostic Medical Systems0.90-0.38-29.69%
FR:ALIKOIkonisys SA1.45-0.01-0.68%
FR:ALMDTMedian Technologies4.361.4047.30%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.